Mushroom extract supplement for lung cancer chemo patients
Part of Cancer, Lungs & breathing clinical trials.
This study tests whether a supplement from a medicinal mushroom (Antrodia cinnamomea, also known as niu zhang zhi) can improve quality of life for people with lung cancer who are receiving platinum-based chemotherapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with lung cancer (confirmed by tests like a biopsy or CT scan).
- You are at least 18 years old.
- You are currently receiving or have recently received platinum-based chemotherapy (a common type of chemo for lung cancer).
- Your doctor expects you to live at least 6 more months.
- You do not have serious liver or kidney problems, active infections, or severe heart issues.
- You are not currently taking hormone therapy or supplements with Antrodia camphorata.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing if an extract from a medicinal mushroom (Antrodia cinnamomea) can help people with liver cancer who have had a treatment called TACE (chemoembolization). It looks at whether the mushroom extract can improve liver health and recovery after the procedure.
This trial tests if taking a probiotic supplement along with your standard lung cancer treatment can help you live longer and respond better to therapy. It is for people with advanced non-small cell lung cancer who have not tried immunotherapy before.
This study looks at whether staged Chinese herbal medicine added to standard treatment can lower the risk of lung cancer coming back or spreading after surgery. It is for people with stage Ib to IIIb non-small cell lung cancer whose tests show no “driver gene” targets.
This study tests whether a probiotic supplement (LR607) can help patients with newly diagnosed non-small cell lung cancer—a common type of lung cancer. Probiotics are beneficial bacteria that may help your immune system fight cancer alongside standard treatments.
This trial tests whether adding a fiber supplement to standard immunotherapy can help treat advanced non-small cell lung cancer. It's for people whose tumors have high PD-L1 levels and no treatable genetic mutations.
This trial tests whether adding nutritional support to standard steroid treatment helps patients recover from severe lung inflammation caused by immune checkpoint inhibitor cancer drugs. The study aims to improve breathing and overall health in patients who develop this serious side effect.
Hear when a new Lung Cancer (Diagnosis) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.